Bailard’s Magellan Health Services, Inc. MGLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-9,345
Closed -$673K 577
2018
Q3
$673K Sell
9,345
-100
-1% -$8.05K 0.04% 284
2018
Q2
$906K Hold
9,445
0.05% 231
2018
Q1
$1.01M Buy
9,445
+100
+1% +$10K 0.06% 216
2017
Q4
$902K Buy
+9,345
New +$827K 0.06% 245
2016
Q4
Sell
-35,228
Closed -$1.89M 331
2016
Q3
$1.89M Buy
35,228
+555
+2% +$33.5K 0.17% 122
2016
Q2
$2.28M Buy
34,673
+48
+0.1% +$3.23K 0.27% 90
2016
Q1
$2.35M Buy
34,625
+30,025
+653% +$1.81M 0.33% 52
2015
Q4
$284K Buy
+4,600
New +$247K 0.12% 171

Other funds holding MGLN

Bailard's MGLN Position: Q4 2018 in Review

Bailard sold out of Magellan Health Services, Inc. (MGLN) in Q4 2018, closing a stake of 9,345 shares — an estimated $673K sold.

Bailard first reported a position in MGLN in Q4 2015 and held it in 8 quarters. The position peaked at $2.35M in Q1 2016. 188 funds tracked by Wall St. Rank hold MGLN as of Q4 2018.

  • Bailard reported no remaining Magellan Health Services, Inc. position as of Q4 2018 after selling out during the quarter.
  • Bailard sold 9,345 Magellan Health Services, Inc. shares in Q4 2018, an estimated $673K.
  • Bailard first reported a position in Magellan Health Services, Inc. in Q4 2015 and held it in 8 quarters.
  • Bailard's Magellan Health Services, Inc. position peaked at $2.35M in Q1 2016.
  • 188 funds tracked by Wall St. Rank held Magellan Health Services, Inc. as of Q4 2018.

Based on Bailard's 13F filing for Q4 2018, filed 5 Feb 2019.